Optimized murine HFpEF models for translational preclinical studies
ESC Heart Failure · 2026
DOI: 10.1093/eschf/xvag072 ↗Kurz gefasst
Fachartikel in der Zeitschrift ESC Heart Failure, 2026. Verfasst von Bailey McIntosh und 8 weiteren Autor:innen. Beteiligte Einrichtung: School of Life and Environmental Sciences, Faculty of Science, The University of Sydney, Camperdown, New South Wales 2050, Australia. Hauptthemen laut MEDLINE: Heart Failure, Stroke Volume, Translational Research, Biomedical. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 34 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Jennie Mackenzie bequest, National Heart Foundation Future Leader Fellowship, NSW Cardiovascular Collaborative.
Abstract (Originalsprache)
Introduction
The most clinically representative murine models of heart failure with preserved ejection fraction (HFpEF) include a ‘2-hit’ model combining nitrosative stress with metabolic perturbation and a ‘3-hit’ model that also includes ageing. Both models have important limitations with regard to substrain and sex.
Methods
The 2-hit model protocol was modified to reproduce HFpEF in both C57BL/6N and 6J mice by increasing L-NAME doses (0.5 g/L to 1.75 g/L) and protocol lengths (7 weeks to 13 weeks). For the 3-hit model, in addition to deoxycorticosterone pivalate (DOCP), we added 1% NaCl drinking water to enhance and prolong the effect of DOCP (‘4-hit’). To maintain the phenotype, a second bolus of DOCP was administered after 8 weeks.
Results
HFpEF was successfully induced in C57BL/6J mice when exposed to a 13-week 2-hit L-NAME protocol with gradually increasing dosage from 1.0 to 1.75 g/L. For the 4-hit mice, a clear HFpEF phenotype was observed in C57BL/6N and 6J mice in both male and females, and maintained for up to 12 weeks.
Conclusion
These modifications ensure the 2-hit model is induced in J substrain of C57BL/6 mice. The 4-hit model prevents aldosterone escape and enhances reproducibility across sexes and substrains.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- School of Life and Environmental Sciences, Faculty of Science, The University of Sydney, Camperdown, New South Wales 2050, Australia.
- Cardiometabolic Medicine, Charles Perkins Centre, The University of Sydney, Camperdown, New South Wales 2050, Australia.
- Charles Perkins Centre, The University of Sydney, Camperdown, New South Wales 2050, Australia.
- The Baird Institute for Applied Heart and Lung Surgical Research, 100 Carillon Ave, Newtown, New South Wales 2042, Australia.
- School of Cardiovascular and Metabolic Health, Glasgow Cardiovascular Research Centre, University of Glasgow, 126 University Place, Glasgow G12 8TA, UK.
- School of Medical Sciences, Faculty of Medicine and Health, The University of Sydney, Camperdown, New South Wales 2050, Australia.
ORCID-Profile: Bailey McIntosh, Eilidh A MacDonald
Förderung
- Jennie Mackenzie bequest
- National Heart Foundation Future Leader Fellowship
- NSW Cardiovascular Collaborative
- NSW Health Early-Mid Career Fellowship
- Clinician-Scientist
- National Heart Foundation Level 3 Future Leader Fellowship
- NHF Vanguard
- NHMRC-MRFF Cardiovascular Health Mission
Zitieren
APA
McIntosh, B., Elbassioni, A. A. M., Raheem, A., MacDonald, E. A., Nicklin, S. A., Koay, Y. C., Cameron, E. R., Loughrey, C. M., & O'Sullivan, J. F. (2026). Optimized murine HFpEF models for translational preclinical studies. ESC Heart Failure. https://doi.org/10.1093/eschf/xvag072
Vancouver
McIntosh B, Elbassioni AAM, Raheem A, MacDonald EA, Nicklin SA, Koay YC, et al. Optimized murine HFpEF models for translational preclinical studies. ESC Heart Failure. 2026. doi:10.1093/eschf/xvag072
BibTeX
@article{McIntosh2026,
author = {McIntosh, Bailey and Elbassioni, Ali Ali Mohamed and Raheem, Anmar and MacDonald, Eilidh A and Nicklin, Stuart A and Koay, Yen Chin and Cameron, Ewan R and Loughrey, Christopher M and O'Sullivan, John F},
title = {Optimized murine HFpEF models for translational preclinical studies},
journal = {ESC Heart Failure},
year = {2026},
doi = {10.1093/eschf/xvag072}
}
EUVIMED